It is likely to be used as a theranostic agent in photodynamic therapy.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:A phthalocyanine--fluorescein conjugate was designed and prepared.
📊
Key Findings & Data:Its photophysical properties (electronic absorption and fluorescence) were determined and compared with those of an analogous derivative functionalized by a simple triazole without chromophore.
💡
Conclusion & Impact:It is likely to be used as a theranostic agent in photodynamic therapy.
A phthalocyanine--fluorescein conjugate was designed and prepared. Its photophysical properties (electronic absorption and fluorescence) were determined and compared with those of an analogous derivative functionalized by a simple triazole without chromophore. It is likely to be used as a theranostic agent in photodynamic therapy.
Özet
A phthalocyanine--fluorescein conjugate was designed and prepared. Its photophysical properties (electronic absorption and fluorescence) were determined and compared with those of an analogous derivative functionalized by a simple triazole without chromophore. It is likely to be used as a theranostic agent in photodynamic therapy.
Kelkar, S. S.; Reineke, T. M. Bioconjugate Chem. 2011, 22, 1879–1903.
Manthe, R. L.; Foy, S. P.; Krishnamurthy, N.; Sharma, B.; Labhasetwar, V. Mol. Pharm. 2010, 7, 1880–1898.
Stasinopoulos, I.; Penet, M. F.; Chen, Z.; Kakkad, S.; Glunde, K.; Bhujwalla, Z. M. NMR Biomed. 2011, 24, 636–647. Paterlini-Br´ echot, P. Futur. Oncol. 2011, 7, 849–871.
Lammers, T.; Kiessling, F.; Hennink, W. E.; Storm, G. Mol. Pharm. 2010, 7, 1899–1912.
Ho, Y.-P.; Leong, K. W. Nanoscale 2010, 2, 60–68.
Pan, D.; Caruthers, S. D.; Chen, J.; Winter, P. M.; Senpan, A.; Schmieder, A. H.; Wickline, S. A.; Lanza, G. M. Future Med. Chem. 2010, 2, 471–490.
Garcia-Bennett, A. E. Nanomed. 2011, 6, 867–877. (a) Pandey, R. K. J. Porphyr. Phthalocya. 2000, 4, 368–373; (b) Macdonald, I. J.; Dougherty, T. J. J. Porphyr. Phthalocya. 2001, 5, 105–129; (c) Josefsen, L. B.; Boyle, R. W. Met.-Based Drugs 2008, 1–24; (d) Ali, H.; van Lier, J. E. Chem. Rev. 1999, 99, 2379–2450. (a) Hudson, R.; Boyle, R. W. J. Porphyr. Phthalocya. 2004, 8, 954–975; (b) Taquet, J.-P.; Frochot, C.; Manneville, V.; Barberi-Heyob, M. Curr. Med. Chem. 2007, 14, 1673–1687; (c) Bugaj, A. M. Photochem. Photobiol. Sci. 2011, 10, 1097–1109; (d) Bullous, A. J.; Alonso, C. M. A.; Boyle, R. W. Photochem. Photobiol. Sci. 2011, 10, 721–750. (a) Makarov, S.; Litwinski, C.; Ermilov, E. A.; Suvorova, O.; R¨ oder, B.; W¨ ohrle, D. Chem. Eur. J. 2006, 12, 1468–1474; (b) Kobayashi, N.; Furuyama, T.; Satoh, K. J. Am. Chem. Soc. 2011, 133, 19642–19645; (c) K¨ o¸ c, M.; G¨ urek, A. G.; Dumoulin, F.; Ahsen, V. Turk. J. Chem. 2012, 36, 493–502.
Garcia, J.; Gonzalez, A.; Gouloumis, A.; Maya, E. M.; Perez, M. D.; Rey, B. D.; Vazquez, P.; Torres, T. Turk. J. Chem. 1998, 22, 23–31. (a) Guillaud, G.; Simon, J.; Germain, J. P. Coord. Chem. Rev. 1998, 178–180, 1433–1484; (b) Zhou R.; Josse F.; G¨ opel, W.; ¨ Ozt¨ urk, Z. Z.; Bekaro˘ glu, ¨ O. Applied Organomet. Chem. 1996, 10, 557–577; (c) Rodriguez-M´ endez, M. L.; Gaya, M.; Antonio de Saja, J. J. Porphyr. Phthalocya. 2009, 13, 1159–1167. (a) Simonneaux, G.; Tagliatesta, P. J. Porphyr. Phthalocya. 2004, 8, 1166–1171; (b) Zagal, J. H.; Griveau, S.; Silva, J. F.; Nyokong, T.; Bedioui, F. Coord. Chem. Rev. 2010, 254, 2755–2791; (c) ˙I¸sci, ¨ U.; Afanasiev, P.; Millet, J.-M. M.; Kudrik, E. V.; Ahsen, V.; Sorokin, A. B. Dalton Trans. 2009, 7410–7420.
Bressan, M.; d’Alessandro, N.; Liberatore, L.; Morvillo, A. Coord. Chem. Rev. 1999, 385, 185–186. (a) Ayhan, M. M.; Singh, A.; Hirel, C.; G¨ urek, A. G.; Ahsen